1. Home
  2. CDXS vs POLE Comparison

CDXS vs POLE Comparison

Compare CDXS & POLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • POLE
  • Stock Information
  • Founded
  • CDXS 2002
  • POLE 2024
  • Country
  • CDXS United States
  • POLE United States
  • Employees
  • CDXS N/A
  • POLE N/A
  • Industry
  • CDXS Major Chemicals
  • POLE
  • Sector
  • CDXS Industrials
  • POLE
  • Exchange
  • CDXS Nasdaq
  • POLE NYSE
  • Market Cap
  • CDXS 332.0M
  • POLE 294.2M
  • IPO Year
  • CDXS 2010
  • POLE 2024
  • Fundamental
  • Price
  • CDXS $5.28
  • POLE $9.98
  • Analyst Decision
  • CDXS Buy
  • POLE
  • Analyst Count
  • CDXS 2
  • POLE 0
  • Target Price
  • CDXS $11.00
  • POLE N/A
  • AVG Volume (30 Days)
  • CDXS 875.4K
  • POLE 3.6K
  • Earning Date
  • CDXS 10-31-2024
  • POLE 01-01-0001
  • Dividend Yield
  • CDXS N/A
  • POLE N/A
  • EPS Growth
  • CDXS N/A
  • POLE N/A
  • EPS
  • CDXS N/A
  • POLE N/A
  • Revenue
  • CDXS $64,446,000.00
  • POLE N/A
  • Revenue This Year
  • CDXS N/A
  • POLE N/A
  • Revenue Next Year
  • CDXS $2.02
  • POLE N/A
  • P/E Ratio
  • CDXS N/A
  • POLE N/A
  • Revenue Growth
  • CDXS N/A
  • POLE N/A
  • 52 Week Low
  • CDXS $2.53
  • POLE $9.94
  • 52 Week High
  • CDXS $6.08
  • POLE $11.05
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 59.97
  • POLE N/A
  • Support Level
  • CDXS $5.42
  • POLE N/A
  • Resistance Level
  • CDXS $6.01
  • POLE N/A
  • Average True Range (ATR)
  • CDXS 0.39
  • POLE 0.00
  • MACD
  • CDXS -0.05
  • POLE 0.00
  • Stochastic Oscillator
  • CDXS 46.67
  • POLE 0.00

About CDXS Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

About POLE ANDRETTI ACQUISITION CORP. II

Andretti Acquisition Corp II is a blank check company.

Share on Social Networks: